Israeli researcher receives EU grant for development of 'electronic nose'

An Israeli researcher has been awarded a grant of € 1.73 million by the EU under its Marie Curie Excellence programme for the development of an 'electronic nose' that can sniff out cancer.

Dr Hossam Haick of the Israel Institute of Technology received the award as part of the EU's efforts to strengthen and encourage young promising scientists.

Dr Haick is 31 years old and also the recipient of the largest grant ever received from the EU by an Israeli researcher. He will be working on artificial olfactory systems or 'electronic noses' aimed at sniffing out and diagnosing cancer at the earliest possible stage before it spreads.

"Realisation of the research goal will enable creating an instrument based on nanometre-sized sensors that can diagnose different cancers and even determine at what stage the disease is," explains Dr Haick. "The diagnosis can be carried out at a very early stage even before the tumour has begun to spread. Thus, treatment will be immediate and will destroy the disease at its inception."

Electronic noses are one example of a growing research area called biomimetics, or biomimicry, which involves human-made applications patterned on natural phenomena.

As an odour is composed of molecules, each of which has a specific size and shape, each of these molecules has a receptor of a corresponding size and shape in the human nose. When a specific receptor receives a molecule, it sends a signal to the brain and the brain identifies the smell associated with that particular molecule. Electronic noses based on the biological model work in a similar manner, substituting sensors for the receptors, and transmitting the signal to a program for processing, instead of the brain.

Dr Haick intends to develop sensor arrays made of nanomaterials, understanding the fundamental chemical, physical, and electrical properties of these nanomaterials and the signal mechanism of these sensors.

He will also be developing the smallest versions of these electronic noses; the 'e-nose on chip', which is a single computer chip containing both the sensors and the processing components.

In addition, to targeting the early diagnosis, detection and screening of a disease, artificial olfactory systems are used in environmental-monitoring, the food industries and security.

For further information, please visit: Technion - Israel Institute of Technology

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...

North West Anglia Works with Clinisys to…

North West Anglia NHS Foundation Trust has replaced two, legacy laboratory information systems with a single instance of Clinisys WinPath. The trust, which serves a catchment of 800,000 patients in North...